BioMarCare Technologies Company
BioMarCare Technologies Ltd. operates as a cancer diagnostics company. It develops multi biomarker based tests that utilize blood or tumor tissue for colorectal malignancies. The company’s products include Colon MarCare Plex, Molecular (RNA) biomarker panel for the detection of both cancer and pre-cancerous polyps in blood and mCRC-STRAT, predictive multi biomarker IHC assay for the stratification of mCRC patients eligible for anti EGFR therapy. The company was formerly known as Incure Ltd. and changed its name to BioMarCare Technologies Ltd. in October 2009. The company was founded in 2002 and is based in Jerusalem, Israel.